Filariasis Elimination and STH Control Programme, Communicable Disease Control, Directorate General of Health Services, Ministry of Health and Family Welfare, Dhaka, Bangladesh.
Centre for Neglected Tropical Diseases, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
PLoS Negl Trop Dis. 2019 Jul 15;13(7):e0007542. doi: 10.1371/journal.pntd.0007542. eCollection 2019 Jul.
The Bangladesh Lymphatic Filariasis (LF) Elimination Programme has made significant progress in interrupting transmission through mass drug administration (MDA) and has now focussed its efforts on scaling up managing morbidity and preventing disability (MMDP) activities to deliver the minimum package of care to people affected by LF clinical conditions. This paper highlights the Bangladesh LF Programme's success in conducting a large-scale cross-sectional survey to determine the number of people affected by lymphoedema and hydrocoele, which enabled clinical risk maps to be developed for targeted interventions across the 34 endemic districts (19 high endemic; 15 low endemic).
METHODOLOGY/PRINCIPAL FINDINGS: In the 19 high endemic districts, 8,145 community clinic staff were trained to identify and report patients in their catchment area. In the 15 low endemic districts, a team of 10 trained field assistants conducted active case finding with cases reported via a SMS mHealth tool. Disease burden and prevalence maps were developed, with morbidity hotspots identified at sub-district level based on a combination of the highest prevalence rates per 100,000 and case-density rates per square kilometre (km2). The relationship between morbidity and baseline microfilaria (mf) prevalence was also examined. In total 43,678 cases were identified in the 19 high endemic districts; 30,616 limb lymphoedema (70.1%; female 55.3%), 12,824 hydrocoele (29.4%), and 238 breast/female genital swelling (0.5%). Rangpur Division reported the highest cases numbers and prevalence of lymphoedema (26,781 cases, 195 per 100,000) and hydrocoele (11661 cases, 169.6 per 100,000), with lymphoedema predominately affecting females (n = 21,652). Rangpur and Lalmonirhat Districts reported the highest case numbers (n = 11,199), and prevalence (569 per 100,000) respectively, with five overlapping lymphoedema and hydrocoele sub-district hotspots. In the 15 low endemic districts, 732 cases were identified; 661 lymphoedema (90.2%; female 39.6%), 56 hydrocoele (7.8%), and 15 both conditions (2.0%). Spearman's correlation analysis found morbidity and mf prevalence significantly positively correlated (r = 0.904; p<0.01).
CONCLUSIONS/SIGNIFICANCE: The Bangladesh LF Programme has developed one of the largest, most comprehensive country databases on LF clinical conditions in the world. It provides an essential database for health workers to identify local morbidity hotspots, deliver the minimum package of care, and address the dossier elimination requirements.
孟加拉国淋巴丝虫病(LF)消除规划在通过大规模药物治疗(MDA)中断传播方面取得了重大进展,现在已将其努力重点扩大到管理发病率和预防残疾(MMDP)活动,以便向受 LF 临床状况影响的人提供最低限度的护理包。本文重点介绍了孟加拉国 LF 规划在进行大规模横断面调查方面的成功经验,以确定淋巴水肿和鞘膜积液患者的人数,从而为针对 34 个流行地区(19 个高度流行地区;15 个低度流行地区)的目标干预措施制定临床风险图。
方法/主要发现:在 19 个高度流行地区,有 8145 名社区诊所工作人员接受了培训,以识别和报告其服务区域内的患者。在 15 个低度流行地区,由 10 名受过培训的现场助理人员通过短信 mHealth 工具进行了主动病例发现。根据每 10 万人口最高流行率和每平方公里病例密度率(km2)的组合,制定了疾病负担和流行率地图,并确定了子区一级的发病率热点。还检查了发病率与基线微丝蚴(mf)流行率之间的关系。在 19 个高度流行地区共发现 43678 例病例;30616 例肢体淋巴水肿(70.1%;女性 55.3%),12824 例鞘膜积液(29.4%)和 238 例乳房/女性生殖器肿胀(0.5%)。朗布尔分区报告的病例数和淋巴水肿(26781 例,每 10 万人 195 例)和鞘膜积液(11661 例,每 10 万人 169.6 例)患病率最高,淋巴水肿主要影响女性(n=21652)。朗布尔和拉蒙吉尔哈特区报告的病例数(n=11199)和患病率(每 10 万人 569 例)最高,有五个重叠的淋巴水肿和鞘膜积液子区热点。在 15 个低度流行地区,发现了 732 例病例;661 例淋巴水肿(90.2%;女性 39.6%),56 例鞘膜积液(7.8%)和 15 例同时存在两种疾病(2.0%)。斯皮尔曼相关性分析发现发病率和 mf 流行率呈显著正相关(r=0.904;p<0.01)。
结论/意义:孟加拉国 LF 规划已经开发了世界上最大、最全面的 LF 临床状况国家数据库之一。它为卫生工作者提供了一个重要的数据库,用于确定当地发病率热点,提供最低限度的护理包,并满足档案消除要求。